| COPD [57.2 % (n = 16)] | Control [42.9 % (n = 12)] | P value |
---|---|---|---|
Male [%(n)] | 81.3 (13) | 50.0 (6) | 0.11 |
Smoking history [mean ± SD] |  |  |  |
Smoking (pack-years) | 71.2 ± 24.1 | 40.1 ± 15.5 | <0.001 |
Years since quitting smoking | 8.9 ± 8.0 | 21.2 ± 9.0 | <0.001 |
Spirometry [mean ± SD] |  |  |  |
FEV1 (L) | 1.1 ± 0.5 | 2.5 ± 0.4 | <0.001 |
FVC (L) | 3.0 ± 0.9 | 3.4 ± 0.7 | 0.18 |
FEV1/FVC % | 38.7 ± 11.4 | 74.7 ± 8.1 | <0.001 |
FEV1 % predicted | 39.1 ± 16.6 | 86.5 ± 9.1 | <0.001 |
FVC % predicted | 74.6 ± 17.1 | 90.8 ± 12.5 | <0.001 |
Inhaled Medications [%(n)] | Â | Â | Â |
Taking inhaled corticosteroid | 81.3 (13) | 0 | <0.001 |
Taking inhaled long acting anticholinergic | 75.0 (12) | 7.7 (1) | <0.001 |
Taking inhaled long acting beta agonist | 81.3 (13) | 0 | <0.001 |
Taking inhaled short acting beta agonist | 81.3 (13) | 0 | <0.001 |